中国临床药理学杂志2018，Vol.34Issue(7)：887-890,4.DOI:10.13699/j.cnki.1001-6821.2018.07.044
儿童肾病治疗中超说明书用药的现状
Status of nephrology off-label uses in the treatment of pediatrics
李欣然 1周双 2陈超阳 1马凌悦 1钟旭辉 1周颖 1崔一民 1丁洁1
作者信息
- 1. 北京大学第一医院药剂科,北京100034
- 2. 北京大学医学部药事管理与临床药学系,北京100191
- 折叠
摘要
Abstract
This paper retrieved an updated version of the kidney disease improving global outcomes (KDIGO) guideline and Chinese Medical Association guideline.By combining Micromedex given Thomson grade,we draw a evidence-based evaluation of off-label drug use in pediatric kidney disease.We concluded updated pediatric nephritic disease guidelines.Doctors and pharmacists should cause the attention,and regard off-label uses of drugs normatively and rationally.关键词
超说明书用药/霉酚酸酯/他克莫司/左旋咪唑/利妥昔单抗Key words
off-label use of drug/mycophenlate mofetil/tacrolimus/mizoribine/levamisole/rituximab分类
医药卫生引用本文复制引用
李欣然,周双,陈超阳,马凌悦,钟旭辉,周颖,崔一民,丁洁..儿童肾病治疗中超说明书用药的现状[J].中国临床药理学杂志,2018,34(7):887-890,4.
